首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1789407

人工器官市場：按器官類型、患者類型、最終用戶、應用、技術和地區分類

Artificial Organ Market, By Organ Type, By Patient Type, By End User, By Application, By Technology, By Geography

出版日期: 2025年07月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年人造器官市場規模估計為215.1億美元，預計到2032年將達到383.2億美元，2025年至2032年的年複合成長率（CAGR）為8.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	215.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	8.60%	2032年預測	383.2億美元

全球人工器官市場代表著醫療技術的革命性前沿，它不僅解決了全球嚴重的捐贈器官短缺問題，也為數百萬個器官衰竭患者帶來了希望。人工器官是用於替代或支持衰竭生物器官功能的人工醫療設備，涵蓋多種技術，包括機械裝置、生物工程組織和混合系統。

市場涵蓋各種類型的器官，包括人工心臟、人工腎臟、人工肺、人工肝臟、人工胰臟和人工肢體，每種器官都採用先進的材料科學、生物相容性工程和精良的製造技術。慢性疾病的增加、人口老化以及生活方式相關的器官衰竭，正在推動對人工器官解決方案的需求。這些挽救生命的技術涵蓋了從支持等待移植患者的臨時橋接裝置，到恢復正常生理功能的永久性器官替代品。

這個市場包括可植入設備和外部支援系統，利用生物材料、3D 列印、組織工程和再生醫學領域的尖端創新。隨著世界各地的醫療保健系統面臨器官捐贈短缺和漫長的等待名單，人造器官已成為一種有前途的替代方案，可提供即時可用性、可自訂的規格，並消除與傳統器官移植相關的免疫排斥風險。

市場動態

全球人工器官市場受到多種強勁市場促進因素的推動，凸顯了其在現代醫療保健中的重要性。主要促進因素是全球捐贈器官的嚴重短缺，目前有超過10萬美國人在器官等待名單上，全球範圍內也有類似的統計數據，這導致對人工替代器官的需求迫切。糖尿病、心血管疾病、腎衰竭和肝硬化等慢性疾病的盛行率不斷上升，加上人口老化，顯著增加了對器官替代解決方案的需求。

生物材料、3D 生物列印、組織工程和奈米技術的進步正在徹底改變人造器官的發展，使設備更加生物相容性、耐用性和功能性。政府支持研發的措施、不斷上漲的醫療成本以及人們對人造器官益處的日益認知，進一步加速了市場的發展。然而，市場面臨重大阻礙，包括非常高的市場開發和製造成本，使人造器官昂貴，許多患者可能無法獲得。嚴格的監管核准流程需要大量的臨床試驗和安全檢驗，這給製造商帶來了漫長的核准時間和巨大的財務障礙。與生物相容性、設備壽命、感染風險和實現自然器官功能相關的技術挑戰仍然是重大障礙。保險公司的報銷有限以及對人造器官部署的倫理擔憂也限制了市場擴張。

儘管面臨諸多挑戰，但隨著醫療基礎設施的改善、醫療旅遊業的蓬勃發展以及可支配收入的不斷提高，新興市場蘊藏著巨大的機會。學術機構、生技公司和醫療設備製造商之間的合作正在促進創新，加速產品開發。人工智慧、機器學習和物聯網技術在人工器官設計中的融合，為能夠即時監測和調整功能的智慧自適應設備帶來了革命性機會，有望徹底改變患者治療效果和市場動態。

本次調查的主要特點

本報告對全球人工器官市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球人工器官市場的主要企業進行了概述。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球人工器官市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
透過分析全球人工器官市場所使用的各種策略矩陣，相關人員將更容易做出決策。

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Asahi Kasei Corporation
Fresenius Medical Care AG
Baxter International Inc.
SynCardia Systems LLC
Jarvik Heart Inc.
Cochlear Limited
Ottobock SE & Co. KGaA
Second Sight Medical Products
Ekso Bionics Holdings Inc.
Abiomed Inc.
Organovo Holdings Inc.
Carmat SA

第 11 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8264

Artificial Organ Market is estimated to be valued at USD 21.51 Bn in 2025 and is expected to reach USD 38.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 21.51 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.60%	2032 Value Projection:	USD 38.32 Bn

The global artificial organ market represents a revolutionary frontier in medical technology, addressing the critical shortage of donor organs worldwide while offering hope to millions of patients suffering from organ failure. Artificial organs, engineered medical devices designed to replace or support the function of failing biological organs, encompass a diverse range of technologies including mechanical devices, bioengineered tissues, and hybrid systems.

This market spans various organ types such as artificial hearts, kidneys, lungs, liver, pancreas, and limbs, each utilizing sophisticated materials science, biocompatibility engineering, and advanced manufacturing techniques. The increasing prevalence of chronic diseases, aging populations, and lifestyle-related organ failures has intensified the demand for artificial organ solutions. These life-saving technologies range from temporary bridging devices that sustain patients awaiting transplants to permanent organ replacements that restore normal physiological function.

The market encompasses both implantable devices and external support systems, leveraging cutting-edge innovations in biomaterials, 3D printing, tissue engineering, and regenerative medicine. As healthcare systems worldwide grapple with organ donor shortages and extended waiting lists, artificial organs emerge as a promising alternative, offering immediate availability, customizable specifications, and elimination of immunological rejection risks associated with traditional organ transplantation.

Market Dynamics

The global artificial organ market is propelled by several compelling drivers that underscore its critical importance in modern healthcare. The primary driver stems from the severe shortage of donor organs worldwide, with over 100,000 Americans currently on organ waiting lists and similar statistics globally, creating an urgent need for artificial alternatives. Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, kidney failure, and liver cirrhosis, coupled with aging populations, significantly amplifies demand for organ replacement solutions.

Technological advancements in biomaterials, 3D bioprinting, tissue engineering, and nanotechnology are revolutionizing artificial organ development, making devices more biocompatible, durable, and functionally superior. Government initiatives supporting research and development, increased healthcare expenditure, and growing awareness about artificial organ benefits further accelerate market growth. However, the market faces substantial restraints including extremely high development and manufacturing costs, making artificial organs expensive and potentially inaccessible to many patients. Stringent regulatory approval processes requiring extensive clinical trials and safety validations create lengthy timelines and significant financial barriers for manufacturers. Technical challenges related to biocompatibility, device longevity, infection risks, and achieving natural organ functionality remain significant hurdles. Limited reimbursement coverage by insurance providers and ethical concerns regarding artificial organ implementation also constrain market expansion.

Despite these challenges, immense opportunities exist through emerging markets with improving healthcare infrastructure, increasing medical tourism, and rising disposable incomes. Collaborative research between academic institutions, biotechnology companies, and medical device manufacturers is fostering innovation and accelerating product development. The integration of artificial intelligence, machine learning, and IoT technologies in artificial organ design presents revolutionary opportunities for smart, adaptive devices that can monitor and adjust their functionality in real-time, potentially transforming patient outcomes and market dynamics.

Key features of the study

This report provides an in-depth analysis of the global artificial organ market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial organ market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include leading Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Asahi Kasei Corporation, Fresenius Medical Care AG, Baxter International Inc., SynCardia Systems LLC, Jarvik Heart Inc., Cochlear Limited, Ottobock SE & Co. KGaA, Second Sight Medical Products, Ekso Bionics Holdings Inc., Abiomed Inc., Organovo Holdings Inc., and Carmat SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial organ market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial organ market.

Market Segmentation

Organ Type Insights (Revenue, USD Bn, 2020 - 2032)
- Artificial Heart
- Ventricular Assist Devices (VADs)
- Total Artificial Hearts (TAHs)
- Artificial Kidney
- Wearable Artificial Kidneys
- Implantable Renal Devices
- Artificial Liver
- Bioartificial Liver Support Systems
- Extracorporeal Liver Assist Devices
- Artificial Pancreas
- Closed-Loop Insulin Delivery Systems
- Implantable Glucose Monitors
- Artificial Lungs
- Extracorporeal Membrane Oxygenation (ECMO)
- Implantable Oxygenators
- Sensory Organs
- Cochlear Implants (Hearing)
- Retinal Implants (Vision)
- Corneal Implants
- Bionic Limbs
- Myoelectric Prosthetics
- Others (Neuro-Controlled Prostheses)
Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
- Neonates
- Pediatric
- Adult
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
- Emergency and Trauma Centers
- Home Care Settings
- Others (Research Institutes, etc.)
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Transplantation
- Chronic Disease Management
- Other Emergency or Acute Care
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Mechanical
- Electronic or Bionic
- Biomechanical Hybrid
- Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Asahi Kasei Corporation
- Fresenius Medical Care AG
- Baxter International Inc.
- SynCardia Systems LLC
- Jarvik Heart Inc.
- Cochlear Limited
- Ottobock SE & Co. KGaA
- Second Sight Medical Products
- Ekso Bionics Holdings Inc.
- Abiomed Inc.
- Organovo Holdings Inc.
- Carmat SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Artificial Organ Market, By Organ Type
- Global Artificial Organ Market, By Patient Type
- Global Artificial Organ Market, By End User
- Global Artificial Organ Market, By Application
- Global Artificial Organ Market, By Technology
- Global Artificial Organ Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Artificial Organ Market, By Organ Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Artificial Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Ventricular Assist Devices (VADs)
  - Total Artificial Hearts (TAHs)
Artificial Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Wearable Artificial Kidneys
  - Implantable Renal Devices
Artificial Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Bioartificial Liver Support Systems
  - Extracorporeal Liver Assist Devices
Artificial Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Closed-Loop Insulin Delivery Systems
  - Implantable Glucose Monitors
Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Extracorporeal Membrane Oxygenation (ECMO)
  - Implantable Oxygenators
Sensory Organs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Cochlear Implants (Hearing)
  - Retinal Implants (Vision)
Corneal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Bionic Limbs
  - Myoelectric Prosthetics
Others (Neuro-Controlled Prostheses)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Organ Market, By Patient Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Organ Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Organ Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Emergency or Acute Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Organ Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Mechanical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Electronic or Bionic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biomechanical Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Organ Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Medical Care AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SynCardia Systems LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jarvik Heart Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cochlear Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ottobock SE & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Second Sight Medical Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ekso Bionics Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Organovo Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Carmat SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies